Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Income from Continuing Operations (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Income from Continuing Operations data on record, last reported at 2898763.0 in Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 58.5% year-over-year to 2898763.0; the TTM value through Sep 2025 reached 13666055.0, down 17.6%, while the annual FY2024 figure was 10877412.0, 48.85% up from the prior year.
  • Income from Continuing Operations reached 2898763.0 in Q3 2025 per COEP's latest filing, up from 4334586.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 100001.0 in Q3 2021 and bottomed at 19179693.0 in Q1 2022.
  • Average Income from Continuing Operations over 5 years is 4969285.42, with a median of 3202621.0 recorded in 2023.
  • The widest YoY moves for Income from Continuing Operations: up 78.43% in 2022, down 13634.12% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 13646799.0 in 2021, then soared by 78.43% to 2942978.0 in 2022, then fell by 27.61% to 3755589.0 in 2023, then increased by 19.81% to 3011765.0 in 2024, then rose by 3.75% to 2898763.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 2898763.0 in Q3 2025, 4334586.0 in Q2 2025, and 3420941.0 in Q1 2025.